PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

New study will examine irritable bowel syndrome as long COVID symptom

Researchers will use a $3.2 million grant from the National Institute of Diabetes and Digestive and Kidney Diseases to study gastrointestinal symptoms as a condition of long COVID.

New study will examine irritable bowel syndrome as long COVID symptom
2023-09-30
(Press-News.org) Researchers with the ongoing Arizona CoVHORT research study at the University of Arizona Mel and Enid Zuckerman College of Public Health were awarded $3.2 million by the National Institute of Diabetes and Digestive and Kidney Diseases for a five-year study of gastrointestinal symptoms, specifically irritable bowel syndrome, as a condition of long COVID.

Led by epidemiologist Kristen Pogreba-Brown, PhD, MPH, the CoVHORT study is a longitudinal research study of COVID-19 and post-COVID conditions. The research team is tracking more than 9,000 participants in Arizona to assess long COVID symptoms, post-COVID-19 health impacts and treatments.

“We have an outstanding team of researchers, staff and students working on the CoVHORT study and investigating a range of long COVID symptoms,” Pogreba-Brown said. “And, we have a large, diverse group of participants, so we gather crucial data that deliver answers about specific symptoms, such as irritable bowel syndrome, and help find effective treatments.”

Irritable bowel syndrome, or IBS, affects an estimated 10-15% of the U.S population and can significantly impair quality of life. It is the most common diagnosis of a group of gastrointestinal disorders and is thought to be related to gut-brain interaction.

IBS has been linked to numerous bacterial, protozoan and viral infections. The risk of developing IBS following an acute gastrointestinal, or GI, infection is approximately 9%. Notably, COVID-19 infection elicits a wide range of GI symptoms, including diarrhea, nausea and vomiting, with reports of acute GI symptoms occurring in more than 60% of patients.

Understanding how COVID-19 impacts the incidence of IBS or exacerbates IBS symptoms has the potential to benefit millions of people, given the scale of the pandemic and ongoing waves of infection with many reports of chronic GI symptoms after acute COVID-19 infection.

The study, “Determining the Incidence, Risk Factors and Biological Drivers of Irritable Bowel Syndrome (IBS) as Part of the Constellation of Post-Acute Sequelae of SARS-CoV-2 Infection (PASC) Outcomes,” will take advantage of the Arizona CoVHORT study’s unique scope and infrastructure to deliver vital data to better evaluate and treat COVID-19-related IBS.

The new research will:

Estimate the incidence of IBS and other GI conditions in participants after COVID-19 infections compared with participants who have not had COVID-19. Determine the role of pre-existing IBS on the development and severity of post-COVID-19 symptoms. Establish mechanisms of IBS following COVID-19 infections, including differences in the fecal microbiome composition and function, the individual’s anti-commensal immune response to the fecal microbiome, and targeted/untargeted serum protein biomarkers among participants who were exposed to COVID-19 and those who were not and participants who do and do not develop IBS. “The awareness of long-COVID and post-COVID-19 health complications has diminished since the pandemic has receded, and yet millions of people still suffer,” said Iman Hakim, MD, PhD, MPH, dean of the Zuckerman College of Public Health, “The CoVHORT research study continues to find answers about long COVID and the symptoms that follow infection – knowledge we can use to find treatments. This is public health in action. I’m so proud of Dr. Pogreba-Brown and her team for the work they do that will improve health for people in the United States and around the world.”

END

[Attachments] See images for this press release:
New study will examine irritable bowel syndrome as long COVID symptom New study will examine irritable bowel syndrome as long COVID symptom 2

ELSE PRESS RELEASES FROM THIS DATE:

Department of Energy announces up to $500 million for basic research to advance the frontiers of science

2023-09-29
WASHINGTON, D.C. - The U.S. Department of Energy (DOE) today announced up to $500 million in funding for basic research in support of DOE’s clean energy, economic, and national security goals. The funding will advance the priorities of DOE’s Office of Science and its major programs, including Advanced Scientific Computing Research, Basic Energy Sciences, Biological and Environmental Research, Fusion Energy Sciences, High Energy Physics, Nuclear Physics, Isotope R&D and Production, and Accelerator R&D and Production. This funding opportunity will help achieve the Biden Administration’s ...

Neural activity associated with motor commands changes depending on context

Neural activity associated with motor commands changes depending on context
2023-09-29
Standing at a crosswalk, the signal changes from “don’t walk,” to “walk.” You might step out into the street straight away, or you might look both ways before you cross. In either scenario, you see the light change, you cross the street. But the context is different; in one case, you didn’t think twice. In the other, you waited; looked to the left and right; saw the coast was clear; then stepped into the street. Researchers have known that certain brain activity when you see the light change and certain brain activity when you step out into the street are the same no matter the context -- there’s a known “pathway” ...

Argonne joins Illinois manufacturers for ​“Makers on the Move” tour

2023-09-29
Manufacturers throughout Illinois will have the chance to learn about working with the Materials Manufacturing Innovation Center (MMIC) at the U.S. Department of Energy’s (DOE) Argonne National Laboratory, when the MMIC gets on the bus for the second annual Makers on the Move tour.  The Illinois Manufacturing Association and Illinois Manufacturing Excellence Center (IMEC) sponsor the eight-day, 1,000-mile tour, designed to showcase high-tech, clean, diverse and sustainable modern manufacturing. The branded Makers on the Move bus will stand out on the state’s roadways as it visits facilities, colleges ...

High cure rate, low toxicity maintained with shortened radiation treatment for intermediate risk prostate cancer, study finds

2023-09-29
ARLINGTON, Va., September 29, 2023 — People with intermediate risk, localized prostate cancer can be treated as effectively using fewer and higher doses of radiation therapy delivered over five treatment sessions as they can with lower doses delivered over several weeks, a new phase III randomized trial suggests. The findings, which are the latest from a series of studies investigating the benefits of stereotactic body radiation therapy (SBRT) for people diagnosed with prostate cancer, will be presented Monday at the American Society for Radiation Oncology (ASTRO) Annual Meeting. The PACE ...

True progression or pseudoprogression in glioblastoma patients?

True progression or pseudoprogression in glioblastoma patients?
2023-09-29
MIAMI, FLORIDA (STRICTLY EMBARGOED UNTIL SEPT. 29, 2023 AT 5PM ET) – Is it true progression or pseudoprogression in tumor growth? That’s the critical question for radiation and medical oncologists treating patients with glioblastoma, the most common and aggressive form of brain cancer. Distinguishing between these types of progression is vitally important for treatment management. “Knowing if it’s true progression, indicative of a poor response to treatment, or pseudoprogression, a favorable response that may look worse due to swelling or tumor necrosis, is essential for clinicians,” said Eric Mellon, MD, PhD, a radiation oncologist and researcher ...

ASTRO 2023 Session shines spotlight on physician burnout

ASTRO 2023 Session shines spotlight on physician burnout
2023-09-29
MIAMI, FLORIDA (EMBARGOED UNTIL SEPT. 29, 2023, AT 5 PM ET, 2023) – Physician burnout was already a trending topic within the medical community before 2020, when the COVID-19 pandemic brought national attention to the issue. Typical stressors such as long hours, poor work-life balance, frustrating insurance denials and cumbersome medical documentation were compounded by new challenges from a novel, deadly virus that killed millions worldwide and necessitated a paradigm shift in care delivery. The side effects were widespread and readily apparent. By late 2021, research by the American Medical Association, Mayo Clinic and Stanford ...

Embargoed Sylvester Comprehensive Cancer Center ASTRO 2023 Tip Sheet

2023-09-29
ALL INFORMATION EMBARGOED UNTIL 5 P.M. ET ON SEPT. 29, 2023   Panel Discussion Getting it All Done – Strategies for Coping With Professional Burnout Crystal Seldon Taswell, MD, Sylvester radiation oncologist and researcher, will co-moderate a panel discussion on physician burnout within radiation oncology and medicine. The discussion, titled “Getting It All Done -- Practical Strategies at All Career Stages,” will include background on the extent of the problem, as well as the curriculum gap for residents regarding time management, balancing ...

University of Cincinnati radiation oncology experts present at national conference

University of Cincinnati radiation oncology experts present at national conference
2023-09-29
University of Cincinnati Cancer Center researchers will present abstracts at the American Society for Radiation Oncology (ASTRO) Annual Meeting, held Oct. 1-4 in San Diego.  Lattice therapy shows promise for safer, more effective treatment  In standard radiation treatment, entire tumors receive the same dose of radiation. Cancer Center researchers including Andrew Frankart, MD, are testing the application of a different method called lattice therapy, and he will present three posters detailing research into lattice therapy ...

MD Anderson Research Highlights: ASTRO 2023 Special Edition

2023-09-29
SAN DIEGO ― The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson’s world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back. This special edition features presentations by MD Anderson researchers at the 2023 American Society for Radiation Oncology (ASTRO) Annual Meeting. Information on all MD Anderson ASTRO Annual Meeting content can be found at MDAnderson.org/ASTRO. Read ...

University of Virginia team’s research offers hope for pulmonary fibrosis patients

University of Virginia team’s research offers hope for pulmonary fibrosis patients
2023-09-29
Using a new recipe for growing blood vessels from living lung tissue in the lab, a University of Virginia School of Engineering and Applied Science research team has developed an analytical tool that could lead to a cure for idiopathic pulmonary fibrosis, or IPF, a lung-destroying disease. Fibrosis is chronic scarring of tissue and it can strike nearly every system in the body. According to the National Institutes of Health, the government estimates that 45% of deaths in the United States can be attributed to fibrotic disorders. In the lungs, fibrosis restricts breathing, so understanding how scarring occurs, and ultimately how to stop it, ...

LAST 30 PRESS RELEASES:

Can bismuth prevent oil leaks – (and save Norwegians billions)?

Atmospheric isotopes reveal 4.5 billion years of volcanism on Jupiter’s moon Io

An ink for 3D-printing flexible devices without mechanical joints

Association for Chemoreception Sciences (AChemS) 46th Annual Meeting

How the Birmingham Drug Discovery Hub created an investment-ready ‘drug library’

Scientists uncover 95 regions of the genome linked to PTSD

AI tool predicts responses to cancer therapy using information from each cell of the tumor

CEOs’ human concern translates into higher stock price

Smoking-related deaths could be reduced if people attending lung cancer screening are offered stop-smoking support

Quick decisions in soccer enhanced by brain’s ability to suppress actions

Recycling CFRP waste is a challenge, but we've found a way to make it work

Advanced nuclear magnetic resonance technique developed to reveal precise structural and dynamical details in zeolites

Advancing performance assessment of a spectral beam splitting hybrid PV/T system with water-based SiO2 nanofluid

Researchers realize target protein stability analysis by time-resolved ultraviolet photodissociation mass spectrometry

Oxygen vacancies mediated ultrathin Bi4O5Br2 nanosheets as efficient piezocatalyst for synthesis of H2O2 from pure water

Warming and exogenous organic matter input affected temperature sensitivity and microbial carbon use efficiency of agricultural soil respiration on the Qinghai-Tibet Plateau

Eco-friendly glue designed by Cal Poly, Geisys Ventures team earns industry 'Innovation Award'

From dreams to reality: unveiling the ideal in situ construction method for lunar habitats and paving the way to Moon colonization

From theory to practice: Study demonstrates high CO2 storage efficiency in shale reservoirs using fracturing technology

What women want: Female experiences to manage pelvic pain

Study finds ChatGPT shows promise as medication management tool, could help improve geriatric health care

Heart failure, not stroke is the most common complication of atrial fibrillation

Antipsychotics for dementia linked to more harms than previously acknowledged

Health improvements occurred worldwide since 2010 despite COVID-19 pandemic, but progress was uneven

Mind the gender gap – Met police least trusted by women

Surrey engineers help Mauritius spot illegal fishing from space

Opioid dependence remains high but stable in Scotland, new surveillance report finds

Protecting brain cells with cannabinol

Calorie restriction study reveals complexities in how diet impacts aging

Atom-by-atom: Imaging structural transformations in 2D materials

[Press-News.org] New study will examine irritable bowel syndrome as long COVID symptom
Researchers will use a $3.2 million grant from the National Institute of Diabetes and Digestive and Kidney Diseases to study gastrointestinal symptoms as a condition of long COVID.